Oppenheimer provided color on Cross Country Healthcare CCRN in a research report published today, regarding Cross Country Healthcare's Q4 2010 earnings report. Oppenheimer has previously given Cross Country Healthcare a Perform rating.
In the report, Oppenheimer states, "The core business segments continued to struggle as revenues in Nurse and Allied Staffing (-9.1% y-y) and Locum Tenens (-16.1% y-y) led to an EBITDA margin of 4.6% (-140 bps y-y). While management is upbeat about the growth in the nursing segment, it expects the Locum Tenens segment to remain challenging."
Shares of Cross Country Healthcare closed Wednesday at $7.47, reflecting no change from Tuesday's market close.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.